Capital Advisors Ltd’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26K Buy
70
+27
+63% +$9.5K ﹤0.01% 649
2026
Q2
$15K Buy
43
+2
+5% +$611 ﹤0.01% 763
2026
Q1
$10K Sell
41
-1
-2% -$249 ﹤0.01% 839
2025
Q4
$12K Buy
42
+2
+5% +$547 ﹤0.01% 776
2025
Q3
$10K Hold
40
– – ﹤0.01% 815
2025
Q2
$9K Buy
40
+39
+3,900% +$8.34K ﹤0.01% 830
2025
Q1
$0 Sell
1
-14
-93% -$3.86K ﹤0.01% 1610
2024
Q4
$5K Buy
15
+1
+7% +$315 ﹤0.01% 956
2024
Q3
$4K Buy
14
+3
+27% +$919 ﹤0.01% 976
2024
Q2
$4K Hold
11
– – ﹤0.01% 967
2024
Q1
$4K Hold
11
– – ﹤0.01% 947
2023
Q4
$4K Hold
11
– – ﹤0.01% 920
2023
Q3
$4K Hold
11
– – ﹤0.01% 904
2023
Q2
$4K Hold
11
– – ﹤0.01% 914
2023
Q1
$4K Hold
11
– – ﹤0.01% 777
2022
Q4
$3K Buy
11
+7
+175% +$1.66K ﹤0.01% 808
2022
Q3
$1K Buy
+4
New +$1.22K ﹤0.01% 1157
2022
Q1
– Sell
-1
Closed – – 1239
2021
Q4
$0 Buy
+1
New +$430 ﹤0.01% 960

Other funds holding WST

Capital Advisors Ltd's WST Position: Q3 2026 in Review

Capital Advisors Ltd increased its West Pharmaceutical (WST) stake by 63% in Q3 2026, buying an estimated $9.5K and bringing the position to 70 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #649.

Capital Advisors Ltd first reported a position in WST in Q4 2021 and has held it in 18 quarters since. 288 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Capital Advisors Ltd held 70 shares of West Pharmaceutical worth $26K as of Q3 2026.
  • Capital Advisors Ltd bought 27 West Pharmaceutical shares in Q3 2026, an estimated $9.5K.
  • West Pharmaceutical made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q3 2026, its #649 holding.
  • Capital Advisors Ltd first reported a position in West Pharmaceutical in Q4 2021 and has held it in 18 quarters since.
  • 288 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Capital Advisors Ltd's 13F filing for Q3 2026, filed 27 Oct 2026.